253 related articles for article (PubMed ID: 11445793)
1. Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency.
Rogers MH; Lwin R; Fairbanks L; Gerritsen B; Gaspar HB
J Pediatr; 2001 Jul; 139(1):44-50. PubMed ID: 11445793
[TBL] [Abstract][Full Text] [Related]
2. Effects of metabolic disorders on the brain: can these effects be reversed with bone marrow transplantation?
Hershey AD
J Pediatr; 2001 Jul; 139(1):9-11. PubMed ID: 11445784
[No Abstract] [Full Text] [Related]
3. Hyperbilirubinemia and rapid fatal hepatic failure in severe combined immunodeficiency caused by adenosine deaminase deficiency (ADA-SCID).
Kühl JS; Schwarz K; Münch A; Schmugge M; Pekrun A; Meisel C; Wahn V; Ebell W; von Bernuth H
Klin Padiatr; 2011 Mar; 223(2):85-9. PubMed ID: 21271505
[TBL] [Abstract][Full Text] [Related]
4. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy.
Hershfield MS
Semin Hematol; 1998 Oct; 35(4):291-8. PubMed ID: 9801258
[TBL] [Abstract][Full Text] [Related]
5. Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro).
Hirschhorn R; Yang DR; Insel RA; Ballow M
Cell Immunol; 1993 Dec; 152(2):383-93. PubMed ID: 8258146
[TBL] [Abstract][Full Text] [Related]
6. Bilateral sensorineural deafness in adenosine deaminase-deficient severe combined immunodeficiency.
Albuquerque W; Gaspar HB
J Pediatr; 2004 Feb; 144(2):278-80. PubMed ID: 14760277
[TBL] [Abstract][Full Text] [Related]
7. [Gene therapy for adenosine deaminase deficiency].
Sakiyama Y
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):27-32. PubMed ID: 8727372
[TBL] [Abstract][Full Text] [Related]
8. Severe combined immunodeficiency: a national surveillance study.
Yee A; De Ravin SS; Elliott E; Ziegler JB;
Pediatr Allergy Immunol; 2008 Jun; 19(4):298-302. PubMed ID: 18221464
[TBL] [Abstract][Full Text] [Related]
9. Carrier frequency of a nonsense mutation in the adenosine deaminase (ADA) gene implies a high incidence of ADA-deficient severe combined immunodeficiency (SCID) in Somalia and a single, common haplotype indicates common ancestry.
Sanchez JJ; Monaghan G; Børsting C; Norbury G; Morling N; Gaspar HB
Ann Hum Genet; 2007 May; 71(Pt 3):336-47. PubMed ID: 17181544
[TBL] [Abstract][Full Text] [Related]
10. ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
Cagdas D; Gur Cetinkaya P; Karaatmaca B; Esenboga S; Tan C; Yılmaz T; Gümüş E; Barış S; Kuşkonmaz B; Ozgur TT; Bali P; Santisteban I; Orhan D; Yüce A; Cetinkaya D; Boztug K; Hershfield M; Sanal O; Tezcan İ
J Clin Immunol; 2018 May; 38(4):484-493. PubMed ID: 29744787
[TBL] [Abstract][Full Text] [Related]
11. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.
Gaspar HB; Bjorkegren E; Parsley K; Gilmour KC; King D; Sinclair J; Zhang F; Giannakopoulos A; Adams S; Fairbanks LD; Gaspar J; Henderson L; Xu-Bayford JH; Davies EG; Veys PA; Kinnon C; Thrasher AJ
Mol Ther; 2006 Oct; 14(4):505-13. PubMed ID: 16905365
[TBL] [Abstract][Full Text] [Related]
12. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
13. Towards a rAAV-based gene therapy for ADA-SCID: from ADA deficiency to current and future treatment strategies.
Silver JN; Flotte TR
Pharmacogenomics; 2008 Jul; 9(7):947-68. PubMed ID: 18597656
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID).
Chan B; Wara D; Bastian J; Hershfield MS; Bohnsack J; Azen CG; Parkman R; Weinberg K; Kohn DB
Clin Immunol; 2005 Nov; 117(2):133-43. PubMed ID: 16112907
[TBL] [Abstract][Full Text] [Related]
15. Management options: SCIDS with adenosine deaminase deficiency.
Hilman BC; Sorensen RU
Ann Allergy; 1994 May; 72(5):395-403; quiz 403-4, 407. PubMed ID: 8179225
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency.
Grunebaum E; Cutz E; Roifman CM
J Allergy Clin Immunol; 2012 Jun; 129(6):1588-93. PubMed ID: 22409989
[TBL] [Abstract][Full Text] [Related]
17. [Severe combined immunodeficiencies: a case of adenosine-deaminase deficit].
Macellaro P; Savarino A; Cucchi G; Lazzati A; Zuccotti GV
Pediatr Med Chir; 2004; 26(3):191-5. PubMed ID: 16366403
[TBL] [Abstract][Full Text] [Related]
18. Five missense mutations at the adenosine deaminase locus (ADA) detected by altered restriction fragments and their frequency in ADA--patients with severe combined immunodeficiency (ADA-SCID).
Hirschhorn R; Ellenbogen A; Tzall S
Am J Med Genet; 1992 Jan; 42(2):201-7. PubMed ID: 1346349
[TBL] [Abstract][Full Text] [Related]
19. Seven novel mutations in the adenosine deaminase (ADA) gene in patients with severe and delayed onset combined immunodeficiency: G74C, V129M, G140E, R149W, Q199P, 462delG, and E337del. Mutations in brief no. 142. Online.
Arrendondo-Vega FX; Santisteban I; Notarangelo LD; El Dahr J; Buckley R; Roifman C; Conley ME; Hershfield MS
Hum Mutat; 1998; 11(6):482. PubMed ID: 10200056
[TBL] [Abstract][Full Text] [Related]
20. Tandem mass spectrometry, but not T-cell receptor excision circle analysis, identifies newborns with late-onset adenosine deaminase deficiency.
la Marca G; Canessa C; Giocaliere E; Romano F; Duse M; Malvagia S; Lippi F; Funghini S; Bianchi L; Della Bona ML; Valleriani C; Ombrone D; Moriondo M; Villanelli F; Speckmann C; Adams S; Gaspar BH; Hershfield M; Santisteban I; Fairbanks L; Ragusa G; Resti M; de Martino M; Guerrini R; Azzari C
J Allergy Clin Immunol; 2013 Jun; 131(6):1604-10. PubMed ID: 23280131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]